Corporate DisclosureSQURPHARMA
SQURPHARMA Corporate Disclosure — 24 March 2020
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 24 March 2020. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
The Company has informed that the Board of Directors has approved agreements with M/s Renata Oncology Ltd. and M/s Apex Pharma Ltd., Dhaka, Bangladesh for contract manufacturing of some products on behalf of the Company to meet increased demand of existing products and to introduce new products.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b0000400572e9
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.